On November 6, 2019, Gordon Keller, PhD, was presented with the 2019 Ogawa-Yamanaka Stem Cell Prize. A world-renowned stem cell scientist, Keller was selected for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and regenerative medicine approaches for many human diseases.
The Ogawa-Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine. The prize was established in 2015 through a generous gift from the late Hiro and Betty Ogawa and is supported by the Gladstone Institutes. It also recognizes the importance of induced pluripotent stem cells (iPSCs), discovered by Gladstone Senior Investigator and Nobel laureate Shinya Yamanaka.
In 2019, Gladstone formed a partnership with the Cell Press group to support this important prize.
Support Discovery Science
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Gladstone’s Catherine Tcheandjieu Gueliatcha Named an ‘Emerging Leader’ by National Academy of Medicine
Article
September 4, 2024
Gladstone’s Catherine Tcheandjieu Gueliatcha Named an ‘Emerging Leader’ by National Academy of Medicine
Tcheandjieu is one of 10 scholars nationwide selected as an emerging leader who's shaping the future of health and medicine.
Awards News Release Heart Failure Data Science and Biotechnology Tcheandjieu Lab AI Big DataJustin Eyquem Named a 2024 Pew-Stewart Scholar for Cancer Research
Article
June 18, 2024
Justin Eyquem Named a 2024 Pew-Stewart Scholar for Cancer Research
Eyquem, an affiliate investigator at Gladstone Institutes, is working to enhance the efficiency of CAR-T therapy, a cancer treatment that modifies T cells to target cancer cells.
Awards News Release Cancer Eyquem LabGladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times
Article
May 10, 2024
Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times
The San Francisco Business Times has named Srivastava as one of the Most Admired CEOs among Bay Area businesses and nonprofits. The cardiologist and stem cell pioneer has served in the top leadership role at Gladstone Institutes since 2018.
Awards Institutional News News Release Congenital Heart Disease Cardiovascular Disease Srivastava Lab